332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster I

Efficacy and safety of adjunctive eptifibatide or argatroban versus control for acute ischemic stroke A systematic review and network meta analysis of randomized control trials

Distribution and risk for bleeding in patients with cancer by anticoagulant therapy exposure

More than a bulk Higher incidence of venous thromboembolism VTE in patients with primary mediastinal B cell lymphoma compared to patients with bulky mediastinal Hodgkin lymphoma

Defining resistance Clinical outcomes based on varying definitions of heparin resistance

Comparative performance of khorana padua and improve VTE risk assessment models for venous thromboembolism risk stratification in hospitalized oncology patients

Real world practices in the management of pediatric iliofemoral deep vein thrombosis results of the elite kids survey from the CHAT consortium

Dysregulation of fibrinolysis and its relationship with blood cellular indices in acute pulmonary embolism

Catheter related risk factors for neonatal venous thrombo embolism A systematic review of the literature

Temporal trends in cancer associated venous thromboembolism mortality A nationwide analysis 1999–2020

Epidemiology of cancer associated venous thromboembolism in a nationwide electronic healthrecord database

VTE management in primary central nervous system neoplasms A retrospective cohort study in a Canadian tertiary center between 2013 and 2023

In hospital outcomes of patients admitted due to first time acute chest syndrome with preexisting pulmonary embolism A nationwide analysis 2016 2022

The score settles it maybe not Navigating postpartum VTE prophylaxis

Safety of prothrombin complex concentrate for emergency surgery according to the oral factor xa inhibitor level

Undiagnosed patent foramen ovale with bi atrial thrombus in transit A case of pulmonary embolism and refractory hypoxia

Predictors of clinically relevant bleeding during extended anticoagulation for cancer associated venous thromboembolism including by cancer site Post hoc analysis of the API CAT randomised trial

Current practices of anticoagulant utilization in pediatric patients with acute myeloid leukemia AML

Enhancing specificity in factor v leiden screening Performance of the hemoclot quanti v l assay